Inflammatory bowel disease (ulcerative colitis). Ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age above 20 and less than 60 years Patients with mild to moderate ulcerative colitis Willingness to participate in the study
Exclusion criteria
Exclusion criteria: Changing the type of medicine used and its dosage during the last month Having other intestinal diseases (malignancies, infectious diseases) Suffering from other inflammatory diseases and kidney diseases and diabetes Pregnancy or breastfeeding Use of antibiotics, or use of pre- or probiotic products, or use of multivitamin and mineral supplements, or use of anti-inflammatory supplements such as w3 and curcumin during the intervention and in the one-month period before the intervention. Smoking and drug use History of hospitalization during the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Illness severity. Timepoint: Before the intervention and 6 weeks later. Method of measurement: 9-point partial Mayo score questionnaire.;Fecal calprotectin levels. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Eliza kit.;Disability due to illness. Timepoint: Before the intervention and 6 weeks later. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences